Evaluation of post-operative complications associated with repeat resection and BCNU wafer implantation in recurrent glioblastoma

The combination of carmustine wafers and temozolomide for the treatment of malignant gliomas. A comprehensive review of the rationale and clinical experience

(2013) A. Gutenberg et al.   JOURNAL OF NEURO-ONCOLOGY

Temporal changes in magnetic resonance imaging characteristics of Gliadel wafers and of the adjacent brain parenchyma

(2012) S. Ulmer et al.   NEURO-ONCOLOGY

Occlusion of surgical opening of the ventricular system with fibrinogen-coated collagen fleece: a case collection study

(2011) Hans Christoph Bock et al.   ACTA NEUROCHIRURGICA

The sequential use of carmustine wafers (Gliadel®) and post-operative radiotherapy with concomitant temozolomide followed by adjuvant temozolomide: a clinical review

(2011) Sanjay Dixit et al.   BRITISH JOURNAL OF NEUROSURGERY

Retrospective Comparison of Chemoradiotherapy Followed by Adjuvant Chemotherapy, With or Without Prior Gliadel Implantation (Carmustine) After Initial Surgery in Patients With Newly Diagnosed High-Grade Gliomas

(2011) Georges Noël et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Carmustine Wafer Implantation When Surgical Cavity Is Communicating with Cerebral Ventricles: Technical Considerations on a Clinical Series

(2011) Alessandro Della Puppa et al.   World Neurosurgery

High-grade malignant glioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

(2010) R. Stupp et al.   ANNALS OF ONCOLOGY

Biodegradable Carmustine Wafers (Gliadel) Alone or in Combination with Chemoradiotherapy: The French Experience

(2010) Philippe Menei et al.   ANNALS OF SURGICAL ONCOLOGY

Incorporating BCNU Wafers into Malignant Glioma Treatment

(2010) Anne Balossier et al.   CLINICAL DRUG INVESTIGATION

Survival comparison between glioblastoma multiforme and other incurable cancers

(2010) B. Tran et al.   JOURNAL OF CLINICAL NEUROSCIENCE

Phase II Trial of Continuous Dose-Intense Temozolomide in Recurrent Malignant Glioma: RESCUE Study

(2010) James R. Perry et al.   JOURNAL OF CLINICAL ONCOLOGY

Effect of imaging and catheter characteristics on clinical outcome for patients in the PRECISE study

(2010) Sabine Mueller et al.   JOURNAL OF NEURO-ONCOLOGY

First-line treatment of malignant glioma with carmustine implants followed by concomitant radiochemotherapy: a multicenter experience

(2010) Hans Christoph Bock et al.   NEUROSURGICAL REVIEW

Risk Management in the Treatment of Malignant Gliomas with BCNU Wafer Implants

(2010) A. Giese et al.   Central European neurosurgery

EXTENT OF RESECTION AND SURVIVAL IN GLIOBLASTOMA MULTIFORME

(2009) et al.   NEUROSURGERY

Use of Gliadel (BCNU) Wafer in the Surgical Treatment of Malignant Glioma: A 10-Year Institutional Experience

(2008) Frank J. Attenello et al.   ANNALS OF SURGICAL ONCOLOGY

Multi-institutional phase II study of temozolomide administered twice daily in the treatment of recurrent high-grade gliomas

(2008) Casilda Balmaceda et al.   CANCER

Safety profile of carmustine wafers in malignant glioma: a review of controlled trials and a decade of clinical experience

(2008) Michael Sabel et al.   CURRENT MEDICAL RESEARCH AND OPINION

Cytotoxic chemotherapeutic management of newly diagnosed glioblastoma multiforme

(2008) Camilo E. Fadul et al.   JOURNAL OF NEURO-ONCOLOGY

A retrospective study of the safety of BCNU wafers with concurrent temozolomide and radiotherapy and adjuvant temozolomide for newly diagnosed glioblastoma patients

(2008) Edward Pan et al.   JOURNAL OF NEURO-ONCOLOGY

Gliadel (BCNU) wafer plus concomitant temozolomide therapy after primary resection of glioblastoma multiforme

(2008) Matthew J. McGirt et al.   JOURNAL OF NEUROSURGERY